Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?

Norbert NdjekaFrancesca ConradieGraeme MeintjesAnja ReuterJennifer A HughesXavier PadanilamNazir IsmailYulene KockIqbal MasterRodolfo RomeroJulian Te RieleMartin EnweremHannetjie FerreiraGary Maartens

Published in: The European respiratory journal (2020)

Keyphrases

drug resistant
sars cov
south africa
multidrug resistant
mycobacterium tuberculosis
acinetobacter baumannii
hiv positive
respiratory syndrome coronavirus
pulmonary tuberculosis
hiv aids
adverse drug
antiretroviral therapy
cystic fibrosis
human immunodeficiency virus